The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial.
about
Prophylactic antibiotic therapy for chronic obstructive pulmonary disease (COPD)The effect of clarithromycin on inflammatory markers in chronic obstructive pulmonary disease: preliminary data.Airways disease: phenotyping heterogeneity using measures of airway inflammation.The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial.Long-term macrolide therapy in chronic obstructive pulmonary disease.Clarithromycin targets neutrophilic airway inflammation in refractory asthma.Update on pharmaceutical and minimally invasive management strategies for chronic obstructive pulmonary disease.Airway bacteria measured by quantitative polymerase chain reaction and culture in patients with stable COPD: relationship with neutrophilic airway inflammation, exacerbation frequency, and lung function.Azithromycin inhibits IL-1 secretion and non-canonical inflammasome activation.A double-blind, randomised, placebo-controlled study of roxithromycin and doxycycline combination, roxithromycin alone, or matching placebo for 12 weeks in adults with frequent exacerbations of chronic obstructive pulmonary disease.Pathogen- and host-directed anti-inflammatory activities of macrolide antibioticsMacrolides in cystic fibrosis.Effects of Low-Dose and Long-Term Treatment with Erythromycin on Interleukin-17 and Interleukin-23 in Peripheral Blood and Induced Sputum in Patients with Stable Chronic Obstructive Pulmonary Disease.Role of macrolide therapy in chronic obstructive pulmonary disease.Antibiotic therapy for exacerbations of chronic obstructive pulmonary disease (COPD).The benefits of long-term systemic antimicrobial therapy in chronic obstructive pulmonary disease.Macrolides: from in vitro anti-inflammatory and immunomodulatory properties to clinical practice in respiratory diseases.Chronic rhinosinusitis: an update on current pharmacotherapy.Suppression of oxidant-induced glutathione synthesis by erythromycin in human bronchial epithelial cells.The Clinical Management Of Lower Respiratory Tract Infections.Macrolide therapy in airways disease.Clarithromycin prevents smoke-induced emphysema in mice.Low-dose clarithromycin therapy modulates Th17 response in non-cystic fibrosis bronchiectasis patients.Le traitement par macrolides en cas de maladie des voies a?riennes.The Immunomodulatory Effects of Macrolides-A Systematic Review of the Underlying Mechanisms.
P2860
Q24202329-F428AF72-E7BC-4CD6-B51C-272F1121DF46Q30943674-020A52B4-0397-4D08-9BE3-7B7D68FF0F46Q33864952-5CE405F4-EBF3-4527-965E-D4538669A800Q34078696-0DBDE9BE-496E-45EB-881D-465732D13DDCQ34373310-89C72A4C-BB5F-4A1D-9794-4AA62505307AQ34703625-A21EBF66-C164-43D0-8CF1-5EA05D849D16Q35028812-B7433B2D-176F-45DA-8095-F384D17EBDE7Q35746774-BF064648-C671-4832-8DB0-749DB6247AB3Q35830510-B11B466A-207B-46E3-9788-BC421687267DQ36035081-8FB66BD5-6624-4FC3-A25E-665A338DCA37Q36072425-F9FA0170-C078-49B3-BEB5-47E2911241DBQ36309930-8C35523F-C242-4E0C-B0C4-587B099CECA4Q36805285-8767D534-97E6-47BB-800E-62B7293639F1Q37319950-2215235F-6BC8-4B11-924D-3B50B19C1929Q37814698-D77BA5D8-D7FA-426B-8D0E-F1D7CFCA552FQ37850201-B41EC00E-15EB-4B11-98D6-D9FEE5D9F85DQ37959271-B050F03E-C5F5-43A0-89E8-01A0E23D2B0CQ38139598-CE13D412-DFF2-4270-8937-C379E2B8C33EQ40046116-BF33E80B-DBF2-439C-9FF4-ED625A96ACD3Q40785029-AF61E4C1-8832-4306-901A-E6148A0BB9CCQ43133980-378C7F7A-FEC8-4662-8D33-3FB27549A89AQ43652179-5562CE08-3DB5-4F48-94B3-242EE07B694CQ44422793-B284F094-C0FC-4143-BD6D-48D406523605Q45897425-D95D2CF6-B35E-46B9-AC8E-62FB74D406C0Q54246461-1C75E741-4CA6-45AD-A73C-DCFFD9AF7845
P2860
The effect of oral clarithromycin on bronchial airway inflammation in moderate-to-severe stable COPD: a randomized controlled trial.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
The effect of oral clarithromy ...... a randomized controlled trial.
@en
The effect of oral clarithromy ...... a randomized controlled trial.
@nl
type
label
The effect of oral clarithromy ...... a randomized controlled trial.
@en
The effect of oral clarithromy ...... a randomized controlled trial.
@nl
prefLabel
The effect of oral clarithromy ...... a randomized controlled trial.
@en
The effect of oral clarithromy ...... a randomized controlled trial.
@nl
P2093
P2860
P1476
The effect of oral clarithromy ...... a randomized controlled trial.
@en
P2093
David Honeybourne
Dev Banerjee
Omer A Khair
P2860
P356
10.2165/00151829-200403010-00007
P577
2004-01-01T00:00:00Z
P6179
1018014396